Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zolpidem-containing medicines regulatory update

EMA's Coordination Group for Mutual Recognition and Decentralised Procedures-Human (CMDh) endorsed a recommendation by the agency's Pharmacovigilance Risk Assessment Committee (PRAC) that the product information of zolpidem-containing medicines used

Read the full 291 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE